Manufacturing of Gene Therapy Products in Sweden
SDP4: How can Sweden become Internationally leading in Gene Therapy?
WHEN: 13:00-14:00, 20th October, 2020
WHERE: ZOOM meeting
Swelife-ATMP project ”SDP4 – Opportunities and challenges for Sweden to become internationally leading in the field of gene therapy” invites you to participate in a webinar to learn about where Swedish gene therapy capabilities are right now and where we have great potential for growth. The findings of the project have been published in a report that can be found on their project page.
13.00 Welcome, intro to SDP4, how have we worked and what was the purpose? Christian Gerdesköld
13.10 Report, content, focus, how have we worked? Linnea Enstedt
13.25 A small companies perspective on manufacture of in vivo gene therapy in Sweden for clinical trial. Karin Agerman
13.40 The need for a structure for commercialisation of advanced therapies – what do we do now? Jim Lund
13.50 Questions from the public and reflections.